# EpiEP

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/epiep

- Industry: Medical Devices & Equipment
- Headquarters: Charlottesville, US
- Website: www.epiep.com
- Total disclosed funding: $2.2M
- Latest round: Series B (May 27, 2014)
- Investors on record: 3

## About

EpiEP, Inc. develops innovative medical devices, particularly the EpiAccess™ system, for epicardial access procedures, enhancing precision and safety in cardiac interventions.EpiEP, Inc. specializes in creating medical devices for heart-related procedures. The company is headquartered in Charlottesville, US and has not undergone any significant business pivots. Pamela Bunes serves as the CEO. EpiEP raised USD 1.20 mn in September 2015 from unspecified investors, which constitutes the total amount the company has raised across all funding rounds. The firm has participated in a total of 12 deals since its inception.EpiEP, Inc. specializes in the EpiAccess™ system, a medical device designed for epicardial access procedures. This patented system utilizes a pressure-guided needle to provide real-time feedback on needle tip positioning, facilitating safe entry into the pericardial space. Targeting hospitals and electrophysiology specialists in the U.S. and European Union, the EpiAccess™ system is FDA cleared in the U.S. and has CE marking for European sales, aiming to improve patient outcomes through minimally invasive cardiac interventions for conditions like ventricular tachycardia, atrial fibrillation, and left atrial appendage ligation.EpiEP, Inc. generates revenue through the sale of its EpiAccess™ system to healthcare providers specializing in electrophysiology. Transactions are direct business-to-business sales, where hospitals and clinics purchase the system as part of their cardiac intervention tools. The sales structure involves a one-time purchase, potentially accompanied by initial training and support for staff. The pricing reflects the advanced nature of the technology and its critical role in procedural safety and effectiveness, and the company partners with healthcare facilities for optimal system usage and clinical training integration.EpiEP, Inc. plans to expand its market reach by targeting additional healthcare providers and geographical regions, particularly focusing on upcoming product launches and market expansion initiatives. The company intends to utilize the funds raised in September 2015 to support these growth strategies, including the development and introduction of new products designed to enhance cardiovascular procedures. Specific release dates for these products have not been disclosed.

## Funding rounds

- Series B, May 27, 2014, $0.8M — Connecticut Innovations, LaunchCapital, Golden Seeds
- Series A, Jul 8, 2011, $1.4M — Connecticut Innovations, LaunchCapital

## Investors

- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series A, Series B
- LaunchCapital (https://capitalatlas.ai/funds/launchcapital) — Series A, Series B
- Golden Seeds (https://capitalatlas.ai/funds/golden-seeds) — Series B